Use of a Molecular Signature Response Classifier to Inform Treatment Selection Improves Clinical Disease Activity Among Patients with Rheumatoid Arthritis Initiating a Biologic or Targeted Synthetic Disease-modifying Antirheumatic Drug [0.03%]
使用分子特征反应分类器指导治疗选择可改善开始接受生物制剂或靶向合成抗风湿病药物治疗的类风湿关节炎患者的临床疾病活动状况
Fenglong Xie,Timothy Beukelman,Nicholas P McCormick et al.
Fenglong Xie et al.
Objective: We assessed the effectiveness of PrismRA to improve clinical outcomes among patients with rheumatoid arthritis (RA) initiating treatment with a biologic or targeted synthetic disease-modifying antirheumatic dru...
New Onset of Fibromyalgia After Exposure to a Combat Environment: A Longitudinal Cohort Study [0.03%]
作战环境暴露后新发纤维肌痛症：一项纵向队列研究
Jay B Higgs,Willie J Hale,Casey L Straud et al.
Jay B Higgs et al.
Objective: Traumatic life events are hypothesized to be triggers for the onset of fibromyalgia. Posttraumatic stress disorder (PTSD) is a common comorbidity of fibromyalgia. However, limited prospective data are available...
Elizabeth L Yanik,Abigail Bridgeman,Erik D Herzog et al.
Elizabeth L Yanik et al.
Objective: Daily rhythms may be critical for maintaining homeostasis of joint tissues. We aimed to investigate the relationships between circadian clock disruption, sleep, and osteoarthritis (OA) risk in humans. ...
Differential Item Functioning on the Patient Health Questionnaire-8 by Disease Subtype, Language, Sex, and Age among People with Systemic Sclerosis: A Scleroderma Patient-centered Intervention Network Cohort Study [0.03%]
系统性硬化病患者的患者健康问卷-8的项目功能差异：基于疾病分型、语言、性别和年龄的一项硬皮病研究
Sophie Hu,Marie-Eve Carrier,Marie-Claude Geoffroy et al.
Sophie Hu et al.
Objective: Somatic items used in depression assessments can potentially overlap with symptoms related to physical illness, including systemic sclerosis (SSc). No studies have looked at whether somatic depression items may...
Impact of Dual Rheumatoid Factor and Anti-Citrullinated Protein Antibody Seropositive, Single Seropositive, and Seronegative Rheumatoid Arthritis on Outcomes [0.03%]
双类风湿因子和抗瓜氨酸蛋白抗体阳性和单一抗体阳性或阴性类风湿关节炎患者的临床结局分析
Rebecca T Brooks,Sara J Achenbach,Vanessa L Kronzer et al.
Rebecca T Brooks et al.
Objectives: The objective of this study was to investigate the association between dual seropositive, single seropositive and seronegative rheumatoid arthritis (RA) with radiographic erosions, disease flares, and mortalit...
Marked Long-term Improvement in Lung Function in Melanoma Differentiation-associated Protein 5 (MDA5) Antibody Positive Dermatomyositis Patients: Experience of a Single Center Longitudinal Cohort in North America [0.03%]
北美单中心纵向队列中DMARDs阳性皮肌炎患者的长期肺功能改善：一项单一中心纵向队列的经验研究报告
Jenice X Cheah,Sangmee S Bae,Tiffany De Leon et al.
Jenice X Cheah et al.
Objective: The objective of this study was to describe the longitudinal disease course and pulmonary outcomes of North American patients with melanoma differentiation-associated gene 5 antibody (MDA5 ab) associated dermat...
Addressing Economic Insecurities Can Improve Patient-Reported Outcomes in Lupus [0.03%]
解决经济不安可改善狼疮患者的报告结果
Jay Patel,Tripti Singh,Meredith Ingersoll et al.
Jay Patel et al.
Background: Economic insecurities, such as food, housing, transportation, and financial challenges, are modifiable risk factors and influence patient-reported outcomes (PROs) in systemic lupus erythematosus (SLE). We exam...
Retractions in rheumatology: trends, causes, and implications for research integrity [0.03%]
风湿病学领域的论文撤稿：趋势、原因及对科研诚信的启示
Anna Maria Vettori,Michele Iudici
Anna Maria Vettori
Objective: We aimed to describe the trends and main reasons for study retraction in rheumatology literature. Methods: We reviewed the R...
SUBCUTANEOUS VERSUS INTRAVENOUS TOCILIZUMAB IN AORTITIS ASSOCIATED WITH GIANT CELL ARTERITIS: MULTICENTER STUDY OF 196 PATIENTS [0.03%]
tocilizumab治疗大动脉炎伴巨细胞动脉炎的皮下注射与静脉给药：一项针对196例患者的多中心研究
Carmen Secada-Gómez,Javier Loricera,Adrián-Martín Gutiérrez et al.
Carmen Secada-Gómez et al.
Background: Aortitis associated with giant cell arteritis (GCA) is a severe manifestation, potentially leading to aneurysms and aortic dissection. Tocilizumab (TCZ) has demonstrated efficacy in the treatment of GCA, both ...